IBSA at the EULAR Congress, Amsterdam, June 2018

IBSA at the EULAR Congress, Amsterdam, June 2018

IBSA is glad to reconfirm its presence at the Annual Congress of The European League Against Rheumatism, that is one of the most relevant congresses in the world of rheumatology. IBSA will participate with a Satellite Symposium which will focus on our highly purified, pharmaceutical-grade chondroitin sulfate, with new evidences that have recently become available. See the full programme here.

All people interested in knowing more about IBSA as leading company in the field of OA and Pain, and about its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous and bolus i.v. diclofenac) are also invited to visit us in the exhibition hall (stand #340B).

Published on

2018 © IBSA Institut Biochimque SA - All rights reserved

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of these cookies. Find out more about how we use cookies and how to manage them by reading our cookie notice. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.